In November 2019, which of the following organisations entered into a licensing agreement with AstraZeneca UK Ltd to introduce novel ready-to-use infusion oncology products in China?

• A. Cipla Limited
• B. Lupin Limited
• C. Aurobindo Pharma Limited
• D. Sun Pharmaceutical Industries Ltd